These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3706365)

  • 1. Outpatient conversion of treatment to potassium-sparing diuretics.
    Ridgeway NA; Ginn DR; Alley K
    Am J Med; 1986 May; 80(5):785-8. PubMed ID: 3706365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
    Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
    Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-blind, comparative study of hydrochlorothiazide/amiloride ('Moduret' 25) and hydrochlorothiazide/triamterene ('dyazide') in elderly patients with congestive heart failure.
    Ghosh AK; Mankikar G; Strouthidis T; Windsor A; Long C; Glover DR
    Curr Med Res Opin; 1987; 10(9):573-9. PubMed ID: 3436153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
    Blume CD; Williams RL
    Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
    Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
    Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma electrolytes in elderly patients taking fixed combination diuretics.
    Bayer AJ; Farag R; Browne S; Pathy MS
    Postgrad Med J; 1986 Mar; 62(725):159-62. PubMed ID: 3714599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
    Zawada ET
    Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
    Williams RL; Clark T; Blume CD
    Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the anti-hypertensive effect of moduretic and thiazides].
    Rosenfeld JB
    Schweiz Med Wochenschr; 1980 Oct; 110(41):1498-501. PubMed ID: 7423177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum potassium concentrations after initiation of captopril therapy.
    Schuna AA; Schmidt GR; Pitterle ME
    Clin Pharm; 1986 Nov; 5(11):920-3. PubMed ID: 3536269
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum magnesium and potassium levels in hypertensive patients after a therapeutic switch from hydrochlorothiazide plus a potassium supplement to maxzide.
    Davidov ME; Becker FE; Hollifield JW
    Am J Med; 1987 Mar; 82(3A):48-51. PubMed ID: 3565425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of amiloride combined with hydrochlorothiazide (Moduretic) in the treatment of hypertension.
    Seedat YK; Naidoo DN
    S Afr Med J; 1973 Jul; 47(28):1219-21. PubMed ID: 4721040
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical changes in black and Indian hypertensive patients on diuretic therapy.
    Bhigjee AI; Seedat YK; Hoosen S; Neerahoo RM; Naidoo K
    S Afr Med J; 1983 Dec; 64(25):969-72. PubMed ID: 6648735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of Moducren and Moduretic and their effect on plasma potassium in essential hypertension.
    Jaffé G; Grimshaw JJ; Vallé-Jones JC; Warnock JM
    Practitioner; 1982 Feb; 226(1364):355-8. PubMed ID: 7088834
    [No Abstract]   [Full Text] [Related]  

  • 15. Essential hypertension: new insights and controversies in treatment with diuretics.
    Houston MC; Johnston PE
    South Med J; 1986 Aug; 79(8):984-90. PubMed ID: 3526575
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
    Casner PR; Dillon KR
    J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
    Damian DJ; McNamee R; Carr M
    BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of moduretic in the treatment of arterial hypertension.
    Salako LA; Falase AO
    Niger Med J; 1973 Jul; 3(3):150-5. PubMed ID: 16366351
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical changes during moduretic treatment of hypertension in African patients.
    Ahaneku JE; Taylor GO; Walker O; Agbedana EO; Salako LA
    Kobe J Med Sci; 1995 Aug; 41(4):83-93. PubMed ID: 8904160
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of effect of piretanide (a potassium-stable diuretic) on serum magnesium.
    Verho M; Irmisch R; de Looze S; Rangoonwala B
    Int J Clin Pharmacol Res; 1987; 7(6):433-42. PubMed ID: 3440634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.